ISG20L2 suppresses bortezomib antimyeloma activity by attenuating bortezomib binding to PSMB5

Author: Yan Yang,¹ Yuhan Gao,¹ Jingcao Huang,¹ Zhuang Yang,² Hongmei Luo,¹ Fangfang Wang,¹ Juan Xu,¹ Yushan Cui,¹ Hong Ding,¹ Zhimei Lin,^1,3 Xinyu Zhai,¹ Ying Qu,¹ Li Zhang,¹ Ting Liu,¹ Lingqun Ye,⁴ Ting Niu,¹ and Yuhuan Zheng¹

Citation: Yang, Y., Gao, Y., Huang, J. et al. ISG20L2 suppresses bortezomib antimyeloma activity by attenuating bortezomib binding to PSMB5. JCI Insight. (2022). https://doi.org/10.1172/jci.insight.157081

Used in this study: Immunodeficient B-NDG Mice